Fornia BioSolutions Inc.
- Founded in: 2015
- Number of employees: 15
- Country: United States
- Investors: Hong Kong based private investment company
- Website: forniabiosolutions.com
Which input provides your business model/core technology towards a bio-based economy?
Fornia’s core technology is an integrated platform, a “one-stop shop” encompassing gene discovering to commercialization of products. Our focus is market profitability driven and our aim is to launch superior microbial products that betters everyday life in the most environmentally friendly way possible. Fornia has always focused on implementing and improvising green chemistry and bio-based recycling in all its R & D work and future product lines.
Which market/clients do you address and which short-term/long-term goals do you have?
Our AI-guided biobased product development platform (AIGBD) is extremely robust and has broad application. We offer both AI-guided protein engineering as well as strain development services to clients from bio-industrial, bio-pharma and environmental sectors of biotech. Our short-term goal is to work with broad spread of clients to improve their commercial pipeline. Our long-term goal is to have our own product pipeline, developed using our advanced technology.
What makes your approach unique compared to other stakeholders in the field?
We provide an integrated platform from gene discovery to commercialization of products. Fornia’s AIGBD platform is disrupting existing technologies today, as it exploits AI with extreme creativity, and in ways that has never explored/ studied before in area of synthetic biology. The results of our cutting-edge AIGBD platform are faster commercialization, significantly better profit margins for clients, and superior bio-products compared to existing market.
You can meet Fornia BioSolutions Inc. at EFIB in Brussels on 30 September – 2 October 2019.